EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Cordycepin: A review of strategies to improve the bioavailability and efficacy

Min Chen iD, Jiahao Luo, Wenming Jiang, Lijing Chen, Longxing Miao, Chunchao Han iD

Phytotherapy Research · 2023-09 · 37 (9) · 3839-3858

DOI: 10.1002/ptr.7921 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2023-06-16. Written by Min Chen and 5 co-authors. Institution: School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Major MEDLINE topics: Cordyceps. Cited 48 times so far (Crossref); 136 references. Funded by: Ji'nan Science and Technology Project, Key Research and Development Program of Shandong Province, Natural Science Foundation of Shandong Province.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Cordycepin is a bioactive compound extracted from Cordyceps militaris . As a natural antibiotic, cordycepin has a wide variety of pharmacological effects. Unfortunately, this highly effective natural antibiotic is proved to undergo rapid deamination by adenosine deaminase (ADA) in vivo and, as a consequence, its half‐life is shortened and bioavailability is decreased. Therefore, it is of critical importance to work out ways to slow down the deamination so as to increase its bioavailability and efficacy. This study reviews recent researches on a series of aspects of cordycepin such as the bioactive molecule's pharmacological action, metabolism and transformation as well as the underlying mechanism, pharmacokinetics and, particularly, the methods for reducing the degradation to improve the bioavailability and efficacy. It is drawn that there are three methods that can be applied to improve the bioavailability and efficacy: to co‐administrate an ADA inhibitor and cordycepin, to develop more effective derivatives via structural modification, and to apply new drug delivery systems. The new knowledge can help optimize the application of the highly potent natural antibiotic‐cordycepin and develop novel therapeutic strategies.

Subjects

MeSH terms (MEDLINE)

CordycepsBiological AvailabilityAdenosine DeaminaseAnti-Bacterial AgentsDeoxyadenosines

Author keywords

ADA inhibitorsadenosine deaminase (ADA)bioavailabilitycordycepincordycepin derivativesnew drug delivery systems

Substances

Adenosine DeaminaseAnti-Bacterial AgentscordycepinDeoxyadenosines

Authors and institutions

  • School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • School of Medicine, Linyi University, Linyi, China.

ORCID profiles: Min Chen, Chunchao Han

Funding

  • Ji'nan Science and Technology Project
  • Key Research and Development Program of Shandong Province
  • Natural Science Foundation of Shandong Province
  • Key Technology Research and Development Program of Shandong

Cite

APA

Chen, M., Luo, J., Jiang, W., Chen, L., Miao, L., & Han, C. (2023). Cordycepin: A review of strategies to improve the bioavailability and efficacy. Phytotherapy Research, 37(9), 3839-3858. https://doi.org/10.1002/ptr.7921

Vancouver

Chen M, Luo J, Jiang W, Chen L, Miao L, Han C. Cordycepin: A review of strategies to improve the bioavailability and efficacy. Phytotherapy Research. 2023;37(9):3839-3858. doi:10.1002/ptr.7921

BibTeX
@article{Chen2023,
  author = {Chen, Min and Luo, Jiahao and Jiang, Wenming and Chen, Lijing and Miao, Longxing and Han, Chunchao},
  title = {Cordycepin: A review of strategies to improve the bioavailability and efficacy},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {9},
  pages = {3839--3858},
  doi = {10.1002/ptr.7921}
}
Start for free →